Bill Sutherland

Stock Analyst at Benchmark Co.

(3.84)
# 1,912
Out of 4,517 analysts
268
Total ratings
43.8%
Success rate
5.4%
Average return

Stocks Rated by Bill Sutherland

Prenetics Global
Jul 15, 2026
Maintained: Buy
Price Target: $30$40
Current: $18.91
Upside: +111.53%
CoreCivic
Jul 7, 2026
Maintained: Buy
Price Target: $36$41
Current: $30.65
Upside: +33.77%
Huron Consulting Group
Jun 16, 2026
Maintained: Buy
Price Target: $215
Current: $118.76
Upside: +81.04%
agilon health
May 21, 2026
Maintained: Buy
Price Target: $13$95
Current: $121.22
Upside: -21.63%
HeartBeam
May 15, 2026
Maintained: Buy
Price Target: $8$5
Current: $0.5752
Upside: +769.26%
Cross Country Healthcare
May 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $13.24
Upside: -
Healthcare Services Group
Apr 23, 2026
Maintained: Buy
Price Target: $28$30
Current: $24.99
Upside: +20.07%
RCM Technologies
Apr 8, 2026
Maintained: Buy
Price Target: $32$36
Current: $27.51
Upside: +30.86%
Nutex Health
Mar 10, 2026
Rated: Buy
Price Target: $300
Current: $164.40
Upside: +82.48%
Surgery Partners
Mar 4, 2026
Maintained: Buy
Price Target: $30$24
Current: $16.64
Upside: +44.23%
Maintained: Buy
Price Target: $50$60
Current: $47.00
Upside: +27.66%
Maintained: Hold
Price Target: n/a
Current: $34.22
Upside: -
Maintained: Buy
Price Target: $4.5
Current: $2.33
Upside: n/a
Maintained: Buy
Price Target: $7
Current: $0.0001
Upside: n/a
Maintained: Buy
Price Target: $8$4
Current: $0.0005
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $10.22
Upside: n/a
Upgraded: Buy
Price Target: $5
Current: $3.40
Upside: n/a
Reiterated: Buy
Price Target: $9$7
Current: $0.617
Upside: n/a
Upgraded: Buy
Price Target: $2
Current: $0.000001
Upside: n/a